CIK 0001831915 · Accelerated filer
Cytek Biosciences, Inc.
Sign in to watch- Ticker
- CTKB
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472547526
- Phone
- (877) 922-9835
- Business address
- 47215 LAKEVIEW BOULEVARD, FREMONT, CA, 94538
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-18 | Barnett Valerie General Counsel | Option exercise | +2,688 | 15,088 | ||
| 2022-05-18 | Barnett Valerie General Counsel | Shares withheld for taxes | −1,047 | $9.65 | $10K | 14,041 |
| 2022-05-18 | Barnett Valerie General Counsel | Option exercise · Restricted Stock Units | −2,688 | 29,570 | ||
| 2022-05-09 | Jiang Wenbin President and CEO | Sale | −20,000 | $8.01 | $160K | 7,896,040 |
| 2022-04-25 | Garland Jonathan Todd Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +46,971 | 46,971 | ||
| 2022-04-25 | Garland Jonathan Todd Chief Commercial Officer | Grant or award · Restricted Stock Units | +31,217 | 31,217 | ||
| 2022-04-19 | Yan Ming Chief Technology Officer | Sale | −20,000 | $10.34 | $207K | 8,122,803 |
| 2022-04-07 | Jiang Wenbin President and CEO | Sale | −20,000 | $10.54 | $211K | 7,916,040 |
| 2022-03-21 | Yan Ming Chief Technology Officer | Sale | −20,000 | $11.64 | $233K | 8,142,803 |
| 2022-03-15 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +241,727 | $12.27 | $3.0M | 13,381,054 |
| 2022-03-14 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +342,143 | $12.35 | $4.2M | 13,139,327 |
| 2022-03-11 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +337,492 | $12.77 | $4.3M | 12,797,184 |
| 2022-03-10 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +256,992 | $12.95 | $3.3M | 12,459,692 |
| 2022-03-09 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +40,154 | $12.99 | $522K | 12,202,700 |
| 2022-03-08 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase | +245,701 | $12.86 | $3.2M | 12,162,546 |
| 2022-03-07 | Yan Ming Chief Technology Officer | Option exercise | +62,456 | $0.25 | $16K | 8,152,248 |
| 2022-03-07 | Yan Ming Chief Technology Officer | Option exercise | +10,555 | $0.92 | $10K | 8,162,803 |
| 2022-03-07 | Yan Ming Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −62,456 | 0 | ||
| 2022-03-07 | Yan Ming Chief Technology Officer | Option exercise · Stock Option (Right to Buy) | −10,555 | 16,111 | ||
| 2022-03-07 | Jiang Wenbin President and CEO | Sale | −18,800 | $12.58 | $237K | 7,937,240 |
Page 46 of 49 · 980 trades